), but that age was not.
Discussion
Various forms of cancer may present different clinical features in the elderly population (Huvos, 1986; Yancik et al.. 1986 Yancik et al.. , 1989 Teeter et al., 1987; Walker et al., 1990) . In the present study. we assessed the clinical features and survival rates in elderly HCC patients of 70 years of age or older. Analysis of demographic features in these patients revealed that HBsAg positivity was significantly less frequent in elderly than in younger patients. Also, the proportion of females gradually increased with increasing age. The exact reasons for there being a greater proportion of females in the elderly group are not clear, but we speculate that slower progression of chronic viral hepatitis in females and lower prevalence of heavy drinkers may partly account for this. Stored sera were available for 164 non-A, non-B patients of the present series, and anti-HCV measured by the secondgeneration enzyme immunoassay (EIA-2, Ortho Diagnostics, Ranitau, NJ, USA) was found in 92%; the age distribution of those 164 patients was similar to that of all the patients included in this study. It has been reported that the elderly are more likely to present at initial diagnosis with advanced stages in the case of ovarian cancer (Yancik et al., 1986) , breast cancer (Yancik et al., 1989 ) and Hodgkin's disease (Walker et al., 1990) . However, this was not the case with HCC. Indeed, it was found that the diagnosis was made at a less advanced stage in terms of the size of the tumour in the elderly than in the younger patients (Table I) . In Japan, patients with liver cirrhosis are encouraged to have examinations using a combination of real-time ultrasonography and AFP measurement at regular intervals for an early detection of HCC (Okuda, 1986) . It is conceivable that the older HCC patients are, the more definite the diagnosis of liver cirrhosis, and as a result they are more likely to undergo such examinations, which, in turn, may lead to early detection of HCC. Increasing age has frequently been reported to have a negative impact on the survival of patients with several types of cancer, such as ovarian cancer (Yancik et al., 1986) , breast cancer (Yancik et al., 1989 ) and Hodgkin's disease (Walker et al.. 1990 ). Again, this was not found to be the case with HCC in this study. The prognosis of the elderly HCC patients was found to be similar to that for the younger cases as assessed by two different analyses. In a stage-matched comparison of elderly and non-elderly patients, the prognosis of the former was not statistically different from that of the latter. Furthermore. in a multivariate analysis using the Cox proportional hazards model age was not selected as an independent negative predictor of survival. The multivariate analyses were also carried out separately in three groups of patients treated by three different modalities (surgery. intraarterial chemotherapy and TAE), and in each case age was not selected as a significant predictor (data not shown). This observation that old age is not a significant negative predictor of survival in HCC patients is at variance with the findings of other studies (involving relatively small numbers of patients) that suggested advanced age to be associated with a shorter survival in HCC (Chlebowski et al.. 1984; Falkson et al., 1988; Calvet et al.. 1990; Okada et al., 1992) . The exact reason for this discrepancy is not clear, but the difference may be explained in part by the prevalence of advanced cases. Indeed, in those previous studies, the majority of patients, most of whom had systemic chemotherapy. had very advanced disease and their median survivals ranged from only 3.3 to 5.6 months. By contrast, the median survival was 13.7 months in this study. Differences in ethnic background of HCC patients might also account for the differences in survival. The current finding obtained with a large number of patients that old age is not necessarily a negative predictor of survival may be encouraging from a therapeutic point of view. Elderly patients were significantly less likely to undergo surgery (Table II) , which is in accordance with a general view that advanced age has an adverse effect on the safe limit of surgical resection. However, percutaneous ethanol injection therapy (Sugiura et al.. 1983; Castells et al., 1993) , which is definitely less invasive than surgery, is increasingly being carried out and so elderly HCC patients may soon have a better survival with somewhat improved prognostic outcome.
